Maximus (NYSE:MMS - Get Free Report) posted its quarterly earnings data on Thursday. The health services provider reported $1.61 EPS for the quarter, topping analysts' consensus estimates of $1.39 by $0.22, Zacks reports. Maximus had a return on equity of 21.95% and a net margin of 5.28%. Maximus updated its FY 2025 guidance to 5.900-6.200 EPS.
Maximus Trading Down 0.1 %
Shares of MMS traded down $0.04 during trading hours on Monday, hitting $69.75. 812,509 shares of the stock traded hands, compared to its average volume of 732,954. The company has a current ratio of 1.72, a quick ratio of 1.49 and a debt-to-equity ratio of 0.82. Maximus has a 1-year low of $68.15 and a 1-year high of $93.97. The firm has a market capitalization of $3.98 billion, a PE ratio of 15.00 and a beta of 0.72. The business has a fifty day moving average of $74.64 and a 200-day moving average of $83.12.
Maximus Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, February 28th. Stockholders of record on Saturday, February 15th will be paid a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 1.72%. The ex-dividend date of this dividend is Friday, February 14th. Maximus's dividend payout ratio (DPR) is presently 25.81%.
Insider Activity
In related news, insider Michelle F. Link sold 2,208 shares of the company's stock in a transaction dated Tuesday, December 3rd. The stock was sold at an average price of $73.83, for a total value of $163,016.64. Following the completion of the sale, the insider now owns 6,567 shares in the company, valued at approximately $484,841.61. This represents a 25.16 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CEO Bruce Caswell acquired 3,500 shares of the company's stock in a transaction that occurred on Tuesday, December 17th. The stock was bought at an average price of $70.64 per share, with a total value of $247,240.00. Following the acquisition, the chief executive officer now directly owns 275,929 shares of the company's stock, valued at $19,491,624.56. The trade was a 1.28 % increase in their position. The disclosure for this purchase can be found here. Insiders have bought 7,063 shares of company stock valued at $502,017 over the last 90 days. 1.60% of the stock is owned by company insiders.
Analyst Upgrades and Downgrades
A number of equities analysts have commented on the company. Raymond James raised Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 price objective on the stock in a research note on Thursday, January 2nd. StockNews.com raised Maximus from a "hold" rating to a "buy" rating in a research note on Thursday.
Check Out Our Latest Analysis on MMS
About Maximus
(
Get Free Report)
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
See Also

Before you consider Maximus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.
While Maximus currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.